Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure allows for selective binding to enzyme active sites, enhancing drug efficacy. Commonly employed in the preparation of tyrosine kinase inhibitors and other bioactive molecules targeting neurological and oncological pathways. Also utilized in medicinal chemistry research for structure-activity relationship (SAR) studies due to its ability to modulate pharmacokinetic properties such as solubility and metabolic stability.